An interventional study of Time Restricted Eating in Time Restricted Eating and Obesity, sponsored by University of Mississippi, Oxford. Completed at 1 site in United States. Open to participants aged 19 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.
Sponsored by University of Mississippi, Oxford · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 113 studies in Intermittent Fasting with a site in United States — 33 open to participants now, 44 under way, none of them phase 3. Intermittent Fasting · United States.
Among the 113 studies in Intermittent Fasting with a site in United States, this one is the 52nd largest by enrollment of the 112 interventional ones that give a count, is one of 16 that started in 2024, is one of 104 with no phase, and was the 89th registered.
334 studies on the registry are indexed under Intermittent Fasting; 100 are open to participants now.
Browse Intermittent Fasting studies →33 of the 113 studies in Intermittent Fasting with a site in United States are open now. Recruiting first, the newest first:
University of Maryland, Baltimore · Sites in United States
Ages 55+
Massachusetts General Hospital · Sites in United States
Ages 18–65
Fred Hutchinson Cancer Center · Sites in United States
Ages 18+
Fred Hutchinson Cancer Center · Sites in United States
Ages 21+
University of California, San Diego · Sites in United States
Ages 18–75
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 74 Intermittent Fasting studies recruiting now, 19 (26%) set no upper age limit and 49 (66%) stop at 75 or younger; 4 take children under 18; 22 take healthy volunteers.
This study: 19 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
113 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 5
First in 2010; this study’s year is marked. 16 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 44 is below the median of 50 across 321 interventional studies indexed under Intermittent Fasting.
Median enrollment 40 across the 112 interventional studies, 100 across the 1 observational. Of the 64 that completed or were terminated, 14 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 113 have an industry lead sponsor. The 10 most frequent:
University of Mississippi, Oxford is the lead sponsor of 12 studies on the registry; none are open to participants now.
University of Mississippi, Oxford has 2 studies filed under Intermittent Fasting — fewer than ten, so there is no comparison to draw.
17 of the studies in Intermittent Fasting with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06386887Case Comprehensive Cancer CenterFasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer | 2026-11 |
| NCT07520786University of GeorgiaChanges in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women | 2026-11 |
| NCT07450118University of DelawareNested Pilot Study Comparing Two Treatments to Reduce Type 2 Diabetes Risk in At-Risk Delawareans | 2026-12 |
| NCT05015504OhioHealthApplication of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus | 2026-12 |
| NCT05943626University of UtahCircadian Intervention to Improve Cardiometabolic Health | 2026-12 |
Add all 17 to your calendar (.ics) → With an account.
Among the 113 studies in Intermittent Fasting with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A randomized controlled trial to determine adherence, acceptability and safety of time restricted eating (TRE) in healthy, sedentary, free-living adults with obesity between the ages of 19-65 years when following 16:8 TRE for 8 weeks. This 9-week study includes a baseline week and 8 weeks of the intervention period. Participants are randomly assigned to the TRE or the non-fasting control group. The TRE group will consume calorie containing food and drink only over an 8 hour period and rest of the 16 hour would be fasting. Adherence to TRE and calorie intake are the primary outcomes. Motivators, facilitators and barriers to TRE, hunger and cravings levels, weight bias internalization, body composition (weight, body fat%, fat mass and muscle mass) , Healthy Eating Index (HEI) to assess diet quality, skin carotenoid levels, disordered eating risk, sleep quality, and perceptions of health and well-being are secondary outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The TRE group will consume calorie-containing food and drinks only over an 8-hour window between 6 a.m. to 8 p.m. for 8 weeks. During the fasting period, they can take only calorie-free fluids.
Behavioral: Time Restricted Eating
They will follow their usual eating patterns and consume food over a period of 12 hours or more.
The intervention group will eat and drink in a prescribed daily feeding window of 8-hour between 6 a.m. to 8 p.m. for 8 weeks and follow their normal exercise and resistance training routines. We will allow +/-1 hour starting and ending times for the eating window while aiming for an 8-hour eating window
Adherence
Percent of days during the 8-week trial when TRE was adhered to as recommended. This will be self-reported daily.
Time frame: 8 weeks
Total calorie intake
Pre and post intervention measurements of calorie intake based on three 24-hour food recall surveys using the NDSR software.
Time frame: During baseline week and week 8 of the intervention
Body weight (kg)
Pre and post intervention measures of body weight.
Time frame: At baseline and at the end of 8 weeks of intervention
24-hour physical activity energy expenditure (PAEE)
GT9X Actigraph accelerometer will be used over 7 days to measure physical activity energy expenditure pre-intervention and during week 8 of the intervention.
Time frame: During baseline week and week 8 of the intervention
Body fat percentage (%)
Pre and post intervention measurements of body fat percentage measured by bioelectrical impedance analyzer.
Time frame: At baseline and at the end of 8 weeks of intervention
Fat-free mass (kg)
Pre and post intervention measurements of body fat-free mass (kg) measured by bioelectrical impedance analyzer.
Time frame: At baseline and at the end of 8 weeks of intervention
Fat mass (kg)
Pre and post intervention measurements of body fat mass (kg) measured by bioelectrical impedance analyzer.
Time frame: At baseline and at the end of 8 weeks of intervention
Hunger and satiety
Pre and post intervention subjective measure of hunger and satiety with the use of a Hunger and Satiety Visual Analog Scale
Time frame: During baseline week and week 8 of the intervention
Sleep quality
Pre and post intervention measure of subjective sleep quality by use of Pittsburgh Sleep Quality Scale.
Time frame: One time during the baseline week and week 8 of the intervention
Diet Quality
Pre and post intervention measurements of diet quality based on three 24-hour food recall surveys at pre- and post collected using the NDSR software and Healthy Eating Index was calculated.
Time frame: During baseline week and week 8 of the intervention
Perceptions of health and well-being
Pre- and post quality of life will be assessed using RAND 36-Item Health Survey 1.0 (SF-36)
Time frame: At baseline and at the end of 8 weeks of intervention
Weight Bias Internalization
Pre- and post weight bias internalization will be assessed using the Weight Bias Internalization Scale (WBIS).
Time frame: At baseline and at the end of 8 weeks of intervention
Disordered eating risk
Pre- and post disordered eating risk will be assessed using Eating Attitude Test (EAT-26) survey scores
Time frame: At baseline and at the end of 8 weeks of intervention
Eating Behavior
Pre and post eating behavior will be assessed using the Three Factor Eating Questionnaire (TFEQ-18). The TFEQ-R18 measures 3 aspects of eating behavior: cognitive restraint, uncontrolled eating, and emotional eating
Time frame: At baseline and at the end of 8 weeks of intervention
Skin carotenoid
Pre- and post skin carotenoid levels will be measured pre and post-intervention using a non-invasive NuSkin Biophotonic scanner which is based on the Resonant Raman Spectroscopy technology.
Time frame: At baseline and at the end of 8 weeks of intervention
Motivators, barriers, and facilitators for following time restricted eating
Motivators, barriers, and facilitators when following time restricted eating will be assessed only in the TRE group. These will be collected as qualitative data in the format of a semi-structured interviews over Zoom.
Time frame: At end of 2nd week and during the 8th week of intervention.
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2024 to primary completion in Aug 2025, 14 months.
Of 259 non-industry interventional studies with no phase under Intermittent Fasting, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 34. This study's 14 months is below that.
Counting every sponsor, half of 265 studies reached it within 17 months; a quarter within 8 and three quarters within 34.
Completion moved once since we started tracking on Sep 25, 2026: Oct 2025 → Aug 2025, on Oct 19, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Mississippi, Oxford